Furthermore, AF-MSCs also target inflammatory pathways associated with autoinflammatory disorders or monogenic inflammation, including PI3K/AKT, mTOR, and NF-κB signaling ([106–108]. The gene discussed is NFKB1; the disease is atrial fibrillation.